Literature DB >> 7776327

Post heart/lung transplantation management.

P A Corris1.   

Abstract

Patients with cystic fibrosis present a challenge to management post-transplantation but the results are comparable with those obtained in patients with other conditions. The increasing population of cystic fibrosis patients who have undergone transplantation will require joint management of such patients by cystic fibrosis specialists and pulmonary transplant specialists. The follow-up of patients with cystic fibrosis following pulmonary transplantation potentially affords us an exciting opportunity to study the natural history of this disease as it affects the extra pulmonary organs.

Entities:  

Mesh:

Year:  1995        PMID: 7776327      PMCID: PMC1295057     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  11 in total

1.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.

Authors:  G J Berry; E M Brunt; D Chamberlain; R H Hruban; R K Sibley; S Stewart; H D Tazelaar
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

2.  Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

Authors:  J M Armitage; R L Kormos; R S Stuart; F J Fricker; B P Griffith; M Nalesnik; R L Hardesty; J S Dummer
Journal:  J Heart Lung Transplant       Date:  1991 Nov-Dec       Impact factor: 10.247

3.  Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma.

Authors:  J Nagington; J Gray
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

4.  Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital.

Authors:  C Dennis; N Caine; L Sharples; R Smyth; T Higenbottam; S Stewart; T Wreghitt; S Large; F C Wells; J Wallwork
Journal:  J Heart Lung Transplant       Date:  1993 Nov-Dec       Impact factor: 10.247

5.  Double-lung transplantation in mechanically ventilated patients with cystic fibrosis.

Authors:  G Massard; H Shennib; D Metras; J Camboulives; L Viard; D S Mulder; C I Tchervenkov; J F Morin; R Giudicelli; M Noirclerc
Journal:  Ann Thorac Surg       Date:  1993-05       Impact factor: 4.330

6.  Osteopenia in adults with cystic fibrosis.

Authors:  L K Bachrach; C W Loutit; R B Moss
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

7.  Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center.

Authors:  F K Gould; R Freeman; C E Taylor; T Ashcroft; J H Dark; P A Corris
Journal:  J Heart Lung Transplant       Date:  1993 Jul-Aug       Impact factor: 10.247

8.  Herpes simplex virus infection in heart-lung transplant recipients.

Authors:  R L Smyth; T W Higenbottam; J P Scott; T G Wreghitt; S Stewart; C A Clelland; J P McGoldrick; J Wallwork
Journal:  Transplantation       Date:  1990-04       Impact factor: 4.939

9.  Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis.

Authors:  D S Milne; A D Gascoigne; T Ashcroft; L Sviland; A J Malcolm; P A Corris
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

Review 10.  Current status of lung transplantation for cystic fibrosis.

Authors:  H Shennib; R Adoumie; M Noirclerc
Journal:  Arch Intern Med       Date:  1992-08
View more
  1 in total

Review 1.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.